Patents/Assignees

MTI Biotech, Inc.

2 patents in portfolio

US12435025utility2025
Triphenylphosphonium-tethered Salicylamine Derivatives
0 cites
US12383515utility2025
Compositions and Methods of Use of Γ-ketoaldehyde Scavengers for Treating, Preventing or Improving Nonalcoholic Fatty Liver Disease (NAFLD), NASH, ALD or Conditions Related to the Liver
0 cites